Remote Monitoring Leads to Early Recognition and Treatment of Critical Arrhythmias in Adults After Atrial Switch Operation for Transposition of the Great Arteries

Nagel, Bert; Janoušek, Jan; Koestenberger, Martin; Maier, Robert; Sauseng, W.; Strenger, Volker; Gamillscheg, Andreas; Zartner, Peter

doi:10.1253/circj.cj-13-0670

Cited by 9 publications

(6 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Pediatric patients at high risk (with and without congenital heart disease) with CIEDs were shown to have good compliance and benefit from remote cardiac monitoring by early identification of arrhythmias and device malfunction [36]. Similar findings were shown in patients with transposition of the great arteries after the atrial switch operation [37]. In 35 patients with Brugada syndrome implanted with an ICD and followed up for 33 months, remote cardiac monitoring resulted in fewer visits and less inappropriate shocks [38].…”

Section: Special Populationsmentioning

confidence: 77%

Remote monitoring of the cardiac rhythm: where do we stand today?

Deftereos

Papoutsidakis

Giannopoulos

et al. 2016

Continuing Cardiol Educ

View full text Add to dashboard Cite

Remote monitoring systems, in their current forms, are networked communication solutions allowing exchange of digitized data from implanted or wearable devices. These data usually include electrocardiographic recordings, but nowadays they may encompass much more than that, allowing a continuously updated knowledge of a multitude of device‐ or patient‐related parameters. Remote monitoring has been shown, as one would have expected, to reduce the need for office visits and allow earlier detection—and thus management—of arrhythmic events. However, although there are hints that they may also be associated with improved clinical outcomes, the absence of randomized trials dictates a cautious interpretation of existing evidence. Furthermore, there are still several questions regarding their cost‐effectiveness, the patient populations that could benefit from them, as well as how the transmitted data should be interpreted and acted upon by physicians. In this review, we present and critically examine the current state of affairs of remote cardiac rhythm monitoring systems. Answer questions and earn CME: https://wileyhealthlearning.com/Activity2/4596216/Activity.aspx

show abstract

Section: Special Populationsmentioning

confidence: 77%

Remote monitoring of the cardiac rhythm: where do we stand today?

Deftereos

Papoutsidakis

Giannopoulos

et al. 2016

Continuing Cardiol Educ

View full text Add to dashboard Cite

show abstract

“…Congenital heart disease is demonstrated as the cause of SCD in %0.02 of patients in a recent autopsy study ( 37 ). Recent developments in telemetric monitorization technology enabled early detection of arrhythmic episodes which would otherwise lead to SCD ( 38 ).…”

Section: Special Considerations In Achdmentioning

confidence: 99%

General Concepts in Adult Congenital Heart Disease

Mutluer

Çeliker

2018

Balkan Med J

View full text Add to dashboard Cite

Congenital heart disease in adults (adult congenital heart disease) is a growing burden for healthcare systems. While infant mortality due to congenital heart disease in the last four decades decreased by almost 3-fold, adult congenital heart disease prevalence increased by more than 2-fold in United States. Adult congenital heart disease prevalence is expected to increase steadily until 2050 in projections. Adult congenital heart disease is a multifaceted problem with many dimensions. This manuscript aims to provide an overview of the common adult congenital heart diseases and summarize important points in management of these diseases with possible problems and complications that the patients and the physicians face.

show abstract

“…Upgrading to CRT should be considered in CHD patients with systemic LV and permanent RV pacing causing LV dyssynchrony and dysfunction, and patients in NYHA class IV as a bridge to heart transplantation. In addition to remote monitoring of devices reducing adverse outcomes in ICD patients with acquired heart disease, it may be beneficial to CHD patients to detect and treat tachyarrhythmia early [111,112].…”

Section: Device Therapymentioning

confidence: 99%

Heart failure in congenital heart disease: A review of clinical status and meta-analysis of diagnostic value of serum natriuretic peptides, and medical and device therapies

Albakri¹

2018

Med Clin Arch

View full text Add to dashboard Cite

Traditional description of heart failure (HF) has been within the context of ischemic, hypertensive, valvular and myopathic disease. This description has contributed to the under-appreciation of HF in adult patients with congenital heart disease (CHD), who also manifest all the pathophysiological criteria constituting the clinical syndrome of HF. In adult CHD patients, heterogeneity of residual substrates predisposes them to an early development of HF, presenting a unique challenge in both categorization and protocol management of HF. As such, current diagnosis and treatment using consensus guidelines developed for HF in general remains unclear if they can serve as a meaningful framework for these patients. In this systematic review and meta-analysis, we review current evidence of this rare but life threatening form of HF affecting a large and growing number of adults. The discussion centers on clinical definition, epidemiology, pathophysiology, diagnosis and management with the view of advancing knowledge of the clinical status of HF in CHD.

show abstract

Remote Monitoring Leads to Early Recognition and Treatment of Critical Arrhythmias in Adults After Atrial Switch Operation for Transposition of the Great Arteries

Cited by 9 publications

References 36 publications

Remote monitoring of the cardiac rhythm: where do we stand today?

Remote monitoring of the cardiac rhythm: where do we stand today?

General Concepts in Adult Congenital Heart Disease

Heart failure in congenital heart disease: A review of clinical status and meta-analysis of diagnostic value of serum natriuretic peptides, and medical and device therapies

Contact Info

Product

Resources

About